Viruses as such

Industry

CPC
C12N2710/24121

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2710/00dsDNA Viruses

Current Industry

C12N2710/24121Viruses as such

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Chimeric poxvirus compositions and uses thereof
- Patent number 12,084,687
- Issue date Sep 10, 2024
- City of Hope
- Yuman Fong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 12,036,279
- Issue date Jul 16, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 11,986,503
- Issue date May 21, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccinia virus mutants useful for cancer immunotherapy
- Patent number 11,884,939
- Issue date Jan 30, 2024
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified orthopoxvirus vectors
- Patent number 11,802,292
- Issue date Oct 31, 2023
- Ottawa Hospital Research Institute
- John C. Bell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oncolytic virus for expression of immune checkpoint modulators
- Patent number 11,779,619
- Issue date Oct 10, 2023
- Transgene S.A.
- Nathalie Silvestre
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Engineered vaccinia virus
- Patent number 11,739,302
- Issue date Aug 29, 2023
- Shenzhen Hua Yao Kang Ming Biopharmaceutical Co., Ltd.
- Ming Yuan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immuno-modulated replication-efficient vaccinia virus strain
- Patent number 11,633,441
- Issue date Apr 25, 2023
- Gerd Sutter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 11,541,087
- Issue date Jan 3, 2023
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immuno-oncolytic therapies
- Patent number 11,478,518
- Issue date Oct 25, 2022
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant vaccinia virus and use thereof
- Patent number 11,452,770
- Issue date Sep 27, 2022
- KOLON LIFE SCIENCE, INC.
- Sujeong Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-cancer oncolytic virus combination therapies and elite respond...
- Patent number 11,433,108
- Issue date Sep 6, 2022
- SUZHOU PRAJNA BIOTECH CO., LTD.
- Minjie Hu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthetic chimeric poxviruses
- Patent number 11,345,896
- Issue date May 31, 2022
- David Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable virus-containing composition
- Patent number 11,306,292
- Issue date Apr 19, 2022
- Janssen Vaccines & Prevention B.V.
- Ahmad Shakeb Sediq
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...
- Patent number 11,285,209
- Issue date Mar 29, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Vaccinia virus mutants useful for cancer immunotherapy
- Patent number 11,242,509
- Issue date Feb 8, 2022
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Stable recombinant MVA vectors comprising modified RSV genes with r...
- Patent number 11,225,673
- Issue date Jan 18, 2022
- Bavarian Nordic A/S
- Robin Steigerwald
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Clonal strains of attenuated vaccinia viruses and methods of use th...
- Patent number 11,149,254
- Issue date Oct 19, 2021
- Genelux Corporation
- Aladar A. Szalay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vaccinia virus vectors related to MVA with extensive genomic symmet...
- Patent number 11,104,884
- Issue date Aug 31, 2021
- Probiogen AB
- Ingo Jordan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Integral membrane protein display on poxvirus extracellular envelop...
- Patent number 10,870,707
- Issue date Dec 22, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oncolytic vaccinia virus mutants and using same for cancer treatment
- Patent number 10,842,835
- Issue date Nov 24, 2020
- Arizona Board of Regents on behalf of Arizona State University
- Bertram Jacobs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 10,765,711
- Issue date Sep 8, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...
- Patent number 10,736,962
- Issue date Aug 11, 2020
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of oil and water emulsions for increasing B cell responses with...
- Patent number 10,653,766
- Issue date May 19, 2020
- Bavarian Nordic A/S
- Cédric Cheminay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified vaccinia virus strains for use in diagnostic and therapeut...
- Patent number 10,584,317
- Issue date Mar 10, 2020
- Genelux Corporation
- Aladar A. Szalay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Integral membrane protein display on poxvirus extracellular envelop...
- Patent number 10,577,427
- Issue date Mar 3, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oncolytic virus for expression of immune checkpoint modulators
- Patent number 10,555,981
- Issue date Feb 11, 2020
- Transgene S.A.
- Nathalie Silvestre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Integral membrane protein display on poxvirus extracellular envelop...
- Patent number 10,550,199
- Issue date Feb 4, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication competent attenuated vaccinia viruses with deletion of...
- Patent number 10,512,662
- Issue date Dec 24, 2019
- Memorial Sloan Kettering Cancer Center
- Liang Deng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunogenic compositions comprising silicified virus and methods of...
- Patent number 9,993,543
- Issue date Jun 12, 2018
- Portland State University
- Kenneth M. Stedman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MODIFIED ORTHOPOXVIRUS VECTORS
- Publication number 20240229069
- Publication date Jul 11, 2024
- OTTAWA HOSPITAL RESEARCH INSTITUTE
- John C. BELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED ORTHOPOXVIRUS VECTORS
- Publication number 20240132913
- Publication date Apr 25, 2024
- OTTAWA HOSPITAL RESEARCH INSTITUTE
- John C. BELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNO-MODULATED REPLICATION-EFFICIENT VACCINIA VIRUS STRAIN
- Publication number 20230346863
- Publication date Nov 2, 2023
- Gerd SUTTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oncolytic Vaccinia Virus
- Publication number 20230293608
- Publication date Sep 21, 2023
- QUEEN MARY UNIVERSITY OF LONDON
- Yaohe Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF MANUFACTURING ACTIVATED IMMUNE CELLS
- Publication number 20230086531
- Publication date Mar 23, 2023
- BIOECLIPSE THERAPEUTICS, INC.
- Pamela Reilly CONTAG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20230057304
- Publication date Feb 23, 2023
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Immuno-Oncolytic Therapies
- Publication number 20230008089
- Publication date Jan 12, 2023
- University of Pittsburgh of the Commonwealth System of Higher Education
- Stephen Howard Thorne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLONAL STRAINS OF ATTENUATED VACCINIA VIRUSES AND METHODS OF USE TH...
- Publication number 20230008052
- Publication date Jan 12, 2023
- Genelux Corporation
- Aladar A. SZALAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHETIC CHIMERIC POXVIRUSES
- Publication number 20230002741
- Publication date Jan 5, 2023
- Tonix Pharmaceuticals Holding Corp.
- David Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VARIANT ONCOLYTIC VACCINIA VIRUS AND METHODS OF USE THEREOF
- Publication number 20230002740
- Publication date Jan 5, 2023
- Ignite Immunotherapy, Inc.
- David H. Kirn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT VACCINIA VIRUS AND PHARMACEUTICAL COMPOSITION COMPRISIN...
- Publication number 20220347244
- Publication date Nov 3, 2022
- KOLON LIFE SCIENCE, INC.
- Sujeong KIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF US...
- Publication number 20220290179
- Publication date Sep 15, 2022
- Astellas Pharma Inc.
- Shinsuke Nakao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ONCOLYTIC VACCINIA VIRUS
- Publication number 20220275347
- Publication date Sep 1, 2022
- KM Biologics Co., Ltd.
- Toshio MURAKAMI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR PRODUCING VIRUS AND HARVEST LIQUID COMPOSITION
- Publication number 20220267713
- Publication date Aug 25, 2022
- HANGZHOU CONVERD CO., LTD.
- Yunfan LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Producer Viruses for Generation of Retroviruses In Situ
- Publication number 20220220505
- Publication date Jul 14, 2022
- KaliVir Immunotherapeutics, Inc.
- Stephen H. THORNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED ONCOLYTIC VIRUSES EXPRESSING PD-L1 INHIBITORS AND USES T...
- Publication number 20220064672
- Publication date Mar 3, 2022
- University of Southern California
- Siyi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
M2-DEFECTIVE POXVIRUS
- Publication number 20220056481
- Publication date Feb 24, 2022
- TRANSGENE
- Patricia KLEINPETER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED ORTHOPOXVIRUS VECTORS
- Publication number 20220056480
- Publication date Feb 24, 2022
- OTTAWA HOSPITAL RESEARCH INSTITUTE
- John C. BELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Modified Extracellular Enveloped Virus
- Publication number 20220049228
- Publication date Feb 17, 2022
- KaliVir Immunotherapeutics, Inc.
- Stephen H. THORNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED VACCINIA VIRUS
- Publication number 20210009965
- Publication date Jan 14, 2021
- Shenzhen Hua Yao Kang Ming Biopharmaceutial Co.,Ltd.
- Ming YUAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED ORTHOPOXVIRUS VECTORS
- Publication number 20200392535
- Publication date Dec 17, 2020
- OTTAWA HOSPITAL RESEARCH INSTITUTE
- John C. BELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNO-MODULATED REPLICATION-EFFICIENT VACCINIA VIRUS STRAIN
- Publication number 20200376051
- Publication date Dec 3, 2020
- Gerd SUTTER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINIA VIRUS MUTANTS USEFUL FOR CANCER IMMUNOTHERAPY
- Publication number 20200339959
- Publication date Oct 29, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang Deng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...
- Publication number 20200316198
- Publication date Oct 8, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isolated Recombinant Oncolytic Poxvirus, Pharmaceutical Composition...
- Publication number 20200289591
- Publication date Sep 17, 2020
- Hangzhou Converd Co., Ltd.
- Jin Fu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...
- Publication number 20200237839
- Publication date Jul 30, 2020
- Memorial Sloan-Kettering Cancer Center
- Liang DENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INTEGRAL MEMBRANE PROTIEN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...
- Publication number 20200216562
- Publication date Jul 9, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE VIRUS-CONTAINING COMPOSITION
- Publication number 20200165577
- Publication date May 28, 2020
- Janssen Vaccines & Prevention B.V.
- Ahmad Shakeb SEDIQ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR PRODUCING VACCINIA VIRUS EXPRESSING FOREIGN GENE
- Publication number 20190367886
- Publication date Dec 5, 2019
- National University Corporation Tottori Tottori University
- Takafumi Nakamura
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL VACCINIA VIRUS VECTORS RELATED TO MVA WITH EXTENSIVE GENOMIC...
- Publication number 20190367887
- Publication date Dec 5, 2019
- ProBioGen AG
- Ingo Jordan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Viruses as such

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Chimeric poxvirus compositions and uses thereof

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Replication competent attenuated vaccinia viruses with deletion of...

Vaccinia virus mutants useful for cancer immunotherapy

Modified orthopoxvirus vectors

Oncolytic virus for expression of immune checkpoint modulators

Engineered vaccinia virus

Immuno-modulated replication-efficient vaccinia virus strain

Replication competent attenuated vaccinia viruses with deletion of...

Immuno-oncolytic therapies

Recombinant vaccinia virus and use thereof

Anti-cancer oncolytic virus combination therapies and elite respond...

Synthetic chimeric poxviruses

Stable virus-containing composition

Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof a...

Vaccinia virus mutants useful for cancer immunotherapy

Stable recombinant MVA vectors comprising modified RSV genes with r...

Clonal strains of attenuated vaccinia viruses and methods of use th...

Vaccinia virus vectors related to MVA with extensive genomic symmet...

Integral membrane protein display on poxvirus extracellular envelop...

Oncolytic vaccinia virus mutants and using same for cancer treatment

Replication competent attenuated vaccinia viruses with deletion of...

Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof...

Use of oil and water emulsions for increasing B cell responses with...

Modified vaccinia virus strains for use in diagnostic and therapeut...

Integral membrane protein display on poxvirus extracellular envelop...

Oncolytic virus for expression of immune checkpoint modulators

Integral membrane protein display on poxvirus extracellular envelop...

Replication competent attenuated vaccinia viruses with deletion of...

Immunogenic compositions comprising silicified virus and methods of...

Patents Applicationslast 30 patents

MODIFIED ORTHOPOXVIRUS VECTORS

MODIFIED ORTHOPOXVIRUS VECTORS

IMMUNO-MODULATED REPLICATION-EFFICIENT VACCINIA VIRUS STRAIN

Oncolytic Vaccinia Virus

METHODS OF MANUFACTURING ACTIVATED IMMUNE CELLS

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

Immuno-Oncolytic Therapies

CLONAL STRAINS OF ATTENUATED VACCINIA VIRUSES AND METHODS OF USE TH...

SYNTHETIC CHIMERIC POXVIRUSES

VARIANT ONCOLYTIC VACCINIA VIRUS AND METHODS OF USE THEREOF

RECOMBINANT VACCINIA VIRUS AND PHARMACEUTICAL COMPOSITION COMPRISIN...

GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF US...

ONCOLYTIC VACCINIA VIRUS

METHOD FOR PRODUCING VIRUS AND HARVEST LIQUID COMPOSITION

Producer Viruses for Generation of Retroviruses In Situ

ENGINEERED ONCOLYTIC VIRUSES EXPRESSING PD-L1 INHIBITORS AND USES T...

M2-DEFECTIVE POXVIRUS

MODIFIED ORTHOPOXVIRUS VECTORS

Modified Extracellular Enveloped Virus

ENGINEERED VACCINIA VIRUS

MODIFIED ORTHOPOXVIRUS VECTORS

IMMUNO-MODULATED REPLICATION-EFFICIENT VACCINIA VIRUS STRAIN

VACCINIA VIRUS MUTANTS USEFUL FOR CANCER IMMUNOTHERAPY

RECOMBINANT MVA OR MVADELE3L EXPRESSING HUMAN FLT3L AND USE THEREOF...

Isolated Recombinant Oncolytic Poxvirus, Pharmaceutical Composition...

REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF...

INTEGRAL MEMBRANE PROTIEN DISPLAY ON POXVIRUS EXTRACELLULAR ENVELOP...

STABLE VIRUS-CONTAINING COMPOSITION

METHOD FOR PRODUCING VACCINIA VIRUS EXPRESSING FOREIGN GENE

NOVEL VACCINIA VIRUS VECTORS RELATED TO MVA WITH EXTENSIVE GENOMIC...